MolDX Local Coverage Determination (DL38043)

Written by Laura Tramontozzi

View Letter

Laura Tramontozzi
Previous

Proposed Local Coverage Determination (LCD) - MolDX: Signatera™ and MinimalResidual Disease Testing for Colorectal Cancer (DL38290)
Next

CMS-1678-P — Hospital Outpatient Prospective Payment System, Proposed Rule – Potential Revisions to the Laboratory Date of Service Policy